intriguing biological implications. While the Ras pathway major effort has been to dissect the genetic events that underlie different aspects of disease development. Dehas been extensively studied in the context of tumorigenesis and in several cell signaling pathways, the nortermining when and in what cell types somatic inactivation of the normal NF1 allele actually occur is critical for mal consequences of regulated Ras activation have been more difficult to examine, especially at an organisunderstanding the basic pathology of any phenotype and is ultimately necessary for elucidating the normal mal level. Numerous studies have suggested that the appropriate level or duration of Ras activity is required function of the gene. This exercise has proven to be surprisingly difficult for many NF1-related symptoms, in for eliciting a specific proliferative or differentiative response. For example, in the pheochromocytoma-derived part because of the complex interactions of cell types in the PNS and CNS. A second major goal has been to PC12 cell line, signals that lead to a transient activation of the Ras-ERK pathway result in proliferation, while dissect NF1 function on a cellular and biochemical level, primarily utilizing isolated cell types that have been immore robust and/or sustained activation of this pathway induce differentiation (Marshall, 1995; Schlessinger, 2000) . plicated in disease development. Finally, in part to assist the aims of these first two goals, animal models recapituFurthermore, while overexpression of activated Ras is typically associated with transformation, in some prilating various disease symptoms have been generated. mary cells it has been shown to induce senescence or growth arrest (Ridley et al., 1988; Serrano et al., 1997) .
NF1 and Peripheral Nerve Sheath Tumors

Dermal Neurofibromas The observation that NF1 patients exhibit a variety of tumorigenic and developmental symptoms underscores
The most common, and perhaps the most complex, feature of NF1 is the development of benign neurofibrothe importance of this fine-tuned regulation of the Ras pathway. Thus, investigating neurofibromin function will mas. The peripheral nerve sheath normally provides structural and metabolic support to nerves and, in the not only yield critical information about this devastating human disease but should also lead to a broader undercase of myelinated fibers, potentiates the conduction of action potentials. The most common tumors can arise standing of the biological consequences and importance of appropriate Ras attenuation. from small nerve radicals or larger nerve branches and grow as discrete lesions in the dermis or epidermis rangIn an attempt to understand NF1 function in a biological context, several approaches have been taken. One ing from 0.1 to several centimeters in diameter (collec- (Figure 3) . However, the interdependency of these cell may be the more prevalent component(s) (Peltonen et al., 1988; Erlandson, 1991) . A consensus is further comtypes has severely hampered the definitive elucidation of the etiology of these lesions. For example, does the plicated by the variability of the cellular composition among tumors and regionally within the same tumor.
initial cellular defect result in the hyperproliferation of one cell type (Schwann cells, perineurial cells, or fibroPlexiform Neurofibromas In contrast to dermal neurofibromas, which are typically blasts) or many? Alternatively, does the initiating signal (from any cell type, including neurons and mast cells) small, plexiform neurofibromas can develop internally along the plexus of major peripheral nerves and become result in an increase in growth factor production, or a decrease in an inhibitory factor, causing a local proliferaquite large, involving an entire limb or body region (Upadhyaya and Cooper, 1998). While these tumors are tive response? Could neurofibromas develop as a result of both paracrine and cell-autonomous defects? Finally, also benign, they can be debilitating and can progress to malignancy. The cellular make-up of these lesions is what is the initial trigger: a second hit mutation, a specific environmental event, or another mechanism? The generally similar to dermal lesions. However, as discussed below, the timing of their development as well answers to these and related questions have been elusive for decades and are only now becoming clarified. as their growth properties may indicate differences in the mechanism of tumor initiation.
The following section will focus on insights gained from human genetic studies and animal models as well as The Normal Nerve and Tumor Development The inherent interdependency of the cell types present questions that remain for the future. in normal peripheral nerves underlies the complexity of neurofibromas (Bennington, 1978) (Figure 3) . The difficulty in detecting these event is involved in the eventual progression to malignancy. However, it is important to note that while dermal mutations may be due to the heterogeneity of cell types in the tumor samples (not all of which would have been neurofibromas never progress to malignancy, secondhit mutations in the NF1 locus have been detected, furpredicted to have undergone a mutational event) and/ or the large size of the gene (335 kb genomic, 9 kb ther supporting the notion that loss of NF1 function is required (in at least one cell type) for benign tumor coding) making the detection of subtle mutations challenging. Importantly, while the recent data demonstrate formation. The Nf1 Ϫ/Ϫ chimeric animals described above also did that second-hit mutations can occur in neurofibromas, it not help to resolve the issue of identifying the initiating proliferative response. However, there appears to be some additional complications in this system. Curiously, cell type. In the subset of chimeric animals that were while Nf1-deficient cells hyperproliferate in response to generated with ES cells carrying a ␤-galactosidase exforskolin, proliferation is diminished in response to GGF pressing transgene, the majority of cells within neurofiand serum in comparison to wild-type cells. Notably, bromas were found to be derived from the Nf1-deficient mor development in the trans mice, these animals did not develop MPNSTs, but rather developed tumors simiSecond-hit mutations have also been detected in dermal neurofibromas, and may initiate their development lar to those observed in the Nf1 ϩ/Ϫ or p53 ϩ/Ϫ parental animals. As was predicted, loss of the wild-type Nf1 or as well. However, because these tumors do not appear until later in life, they may arise as a result of a mutation p53 allele (but not both) was observed in these tumors, most likely due to the mutational mechanism described that occurs during adolescence or early adulthood. Alternatively, some believe that second-hit mutations are above. Taken These results support the hypothesis that NF1 is required for normal neuronal function in flies. Interestingly, vitro, and in response to ischemia in vivo in a rat model system (Giordano et al., 1996 ). These observations have these studies also implicate a defect other than Ras regulation in these phenotypes (see below). led to the speculation that in response to injury or ischemia, neurofibromin may normally act as a growth inhibiNf1 ϩ/Ϫ mice also appear to recapitulate some learning disabilities associated with NF1 (Silva et al., 1997). Silva tor and/or promote astrocyte differentiation. However, in the absence of neurofibromin, these signals may lead and colleagues have found that these mice exhibit disrupted spatial learning and contextual discrimination. As to proliferation, and in this way may participate in tumor development. Thus, an inappropriate response to injury in humans, these phenotypes were variably expressed. Further studies utilizing these mice, as well as flies, has been speculated to play a role in NF1-related glial tumors in both the CNS (astrocytomas) and PNS (neuroshould help further dissect the mechanism underlying learning disabilities associated with the human disease. fibromas). Interestingly, there also appears to be an effect of haploinsufficiency on astrocyte proliferation; Nf1 ϩ/Ϫ astrocytes exhibit proliferative defects in vitro NF1 Function in Neural Crest-Derived Tissues and an increased number of astrocytes in the brains of Many NF1-associated symptoms suggest a general role NF1 patients as well as Nf1 ϩ/Ϫ mice have been observed for neurofibromin in neural crest-derived tissues (Upad-(Nordlund, 1995; Gutmann et al., 1999). However, it is hyaya and Cooper, 1998). Two of the cell types that not yet clear that these defects are completely cell aucomprise neurofibromas, Schwann cells and peripheral tonomous. Given that astrocytes can respond to signals neurons, are derived from the neural crest. Similarly, from neurons, and that NF1 mutations would be present pheochromocytomas, which arise from the chromaffin in neurons as well as astrocytes, it is possible that the cells of the adrenal medulla in NF1 patients, are also increased number of astrocytes in NF1 patients and neural crest-derived. Skin hyperpigmentation in NF1 paheterozygous mice may be due to or compounded by tients has also been attributed to defects in neural crestdefects in neurons. Interestingly, mice carrying a neuderived melanocytes, although keratinocytes (or abnorronal-specific targeted disruption of the Nf1 gene also mal interactions between these two cell types) may also exhibit an increase in astrocytes in the brain, supporting play a role in their development (Upadhyaya and Cooper, this possibility (L. Parada., personal communication). 1998). However, it is notable that iris Lisch nodules are While NF1-associated astrocytomas are typically bealso melanocytic lesions. Finally, bone dyplasia affectnign, they can occasionally progress to high grade gliing the skull and face of some NF1 patients also appears oblastomas. Nf1 ϩ/Ϫ mice do not develop these lesions; to originate from defects in neural crest-derived craniohowever, mice carrying Nf1 and p53 mutations in cis facial bones. can develop astrocytomas, of varying grades, with high Phenotypes in Nf1-deficent mice also suggest a funcfrequency. In 3 out of 5 tumors analyzed, LOH was obtion for neurofibromin in both neural crest-derived and served at both loci supporting the role of neurofibromin adjacent non-neural-crest-derived cells. Nf1 Ϫ/Ϫ embryos inactivation and implicating p53 in this process as well die at midgestation (at approximately E14) due to a heart (Reilly et al., 2000) . Interestingly, tumor development defect known as double outlet right ventricle (DORV) appears to be highly dependent on the genetic back-(Brannan et al., 1994; Jacks et al., 1994). This defect is ground of these mice. Therefore, this model may be thought to result from improper rotation and septation useful in probing the potential involvement of modifier of the outflow tract of the developing heart. Importantly, loci in this phenotype.
cardiac neural crest cells have been shown to contribute to these tissues in vertebrates and have therefore been suggested to underlie this defect (Epstein, 2000 effects, perhaps through augmentation of Ras signaling 1997). These phenotypes were not rescued by regulating pathways. These observations may have implications Ras1 signaling and instead were restored by an actithat extend beyond neurofibromatosis type 1, given the vated protein kinase A (PKA) transgene, implicating a high mutational frequency of the NF1 gene. role for NF1 in the regulation of this pathway. These reports also suggest that, in this system, NF1 appears to act at or upstream of the rutabaga-encoded adenylyl
Concluding Remarks
From the pleotropic symptoms exhibited by NF1 pacyclase.
However, while these data do suggest a convergence tients, the defects observed in mice carrying targeted mutations in the Nf1 DeClue, J.E., Heffelfinger, S., Benvenuto, G., Ling, B., Li, S., Rui, W.,
